IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis

Journal of the American Society of Nephrology

Volumn 21, Issue 7, 2010, Pages 1103-1114

  Van Timmeren, Mirjan M ^a   Van Der Veen, Betty S ^a   Stegeman, Coen A ^a   Petersen, Arjen H ^a   Hellmark, Thomas ^b   Collin, Mattias ^c   Heeringa, Peter ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLYCOSIDASE S; GLYCOSIDASE; IMMUNOGLOBULIN G; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGRANULATION; FEMALE; HEMATURIA; HUMAN; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LEUKOCYTURIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RESPIRATORY BURST; SYSTEMIC THERAPY;

EID: 77954614475     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009090984     Document Type: Article

References (39)

1. Kallenberg CG, Heeringa P, Stegeman CA: Mechanisms of disease: Pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol 2: 661-670, 2006
2. Franssen CF, Stegeman CA, Kallenberg CG, Gans RO, De Jong PE, Hoorntje SJ, Tervaert JW: Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int 57: 2195-2206, 2000
3. Turnbull J, Harper L: Adverse effects of therapy for ANCA-associated vasculitis. Best Pract Res Clin Rheumatol 23: 391-401, 2009
4. van Timmeren MM, Chen M, Heeringa P: Review article: Pathogenic role of complement activation in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Nephrology (Carlton) 14: 16-25, 2009
5. Heeringa P, Huugen D, Tervaert JW: Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: A sticky connection? Trends Immunol 26: 561-564, 2005
6. Mulder AH, Heeringa P, Brouwer E, Limburg PC, Kallenberg CG: Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): A Fc gamma RII-dependent process. Clin Exp Immunol 98: 270-278, 1994 (Pubitemid 24336825)
7. Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, Kimberly RP: Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 153: 1271-1280, 1994 (Pubitemid 24228519)
8. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110: 955-963, 2002
9. Huugen D, Xiao H, van Esch A, Falk RJ, Peutz-Kootstra CJ, Buurman WA, Tervaert JW, Jennette JC, Heeringa P: Aggravation of antimyeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: Role of tumor necrosis factor-alpha. Am J Pathol 167: 47-58, 2005
10. Xiao H, Heeringa P, Liu Z, Huugen D, Hu P, Maeda N, Falk RJ, Jennette JC: The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 167: 39-45, 2005
11. Nolan SL, Kalia N, Nash GB, Kamel D, Heeringa P, Savage CO: Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo. J Am Soc Nephrol 19: 973-984, 2008
12. Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC: Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 170: 52-64, 2007
13. Raju TS: Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr Opin Immunol 20: 471-478, 2008
14. Collin M, Olsen A: EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J 20: 3046-3055, 2001
15. Collin M, Shannon O, Bjorck L: IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions. Proc Natl Acad Sci U S A 105: 4265-4270, 2008
16. Allhorn M, Olin AI, Nimmerjahn F, Collin M: Human IgG/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysis. PLoS ONE 3: e1413, 2008 (Pubitemid 351234505)
17. Albert H, Collin M, Dudziak D, Ravetch JV, Nimmerjahn F: In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc Natl Acad Sci U S A 105: 15005-15009, 2008
18. Nandakumar KS, Collin M, Olsen A, Nimmerjahn F, Blom AM, Ravetch JV, Holmdahl R: Endoglycosidase treatment abrogates IgG arthritogenicity: Importance of IgG glycosylation in arthritis. Eur J Immunol 37: 2973-2982, 2007
19. Collin M, Fischetti VA: A novel secreted endoglycosidase from Enterococcus faecalis with activity on human immunoglobulin G and ribonuclease B. J Biol Chem 279: 22558-22570, 2004
20. van Rossum AP, Rarok AA, Huitema MG, Fassina G, Limburg PC, Kallenberg CG: Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies. J Leukoc Biol 76: 1162-1170, 2004
21. Falk RJ, Terrell RS, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 87: 4115-4119, 1990
22. Kocher M, Edberg JC, Fleit HB, Kimberly RP: Antineutrophil cytoplasmic antibodies preferentially engage Fc gammaRIIIb on human neutrophils. J Immunol 161: 6909-6914, 1998
23. Kettritz R, Jennette JC, Falk RJ: Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol 8: 386-394, 1997 (Pubitemid 127454174)
24. Nimmerjahn F, Ravetch JV: Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8: 34-47, 2008
25. Xiao H, Heeringa P, Schreiber A, Falk RJ, Jennette JC: The role of Fc gamma receptors in induction of glomerulonephritis and pulmonary granulomatous inflammation in mice by anti-myeloperoxidase antibodies (anti-MPO) [Abstract]. J Am Soc Nephrol 15: 37A, 2004
26. Huugen D, van Esch A, Xiao H, Peutz-Kootstra CJ, Buurman WA, Tervaert JW, Jennette JC, Heeringa P: Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int 71: 646-654, 2007
27. Bajema IM, Hagen EC, Hermans J, Noel LH, Waldherr R, Ferrario F, van der Woude FJ, Bruijn JA: Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56: 1751-1758, 1999
28. Neumann I, Kain R, Regele H, Soleiman A, Kandutsch S, Meisl FT: Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant 20: 96-104, 2005
29. Little MA, Smyth CL, Yadav R, Ambrose L, Cook HT, Nourshargh S, Pusey CD: Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 106: 2050-2058, 2005
30. Little MA, Smyth L, Salama AD, Mukherjee S, Smith J, Haskard D, Nourshargh S, Cook HT, Pusey CD: Experimental autoimmune vasculitis: An animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis. Am J Pathol 174: 1212-1220, 2009
31. Holland M, Takada K, Okumoto T, Takahashi N, Kato K, Adu D, Ben-Smith A, Harper L, Savage CO, Jefferis R: Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Clin Exp Immunol 129: 183-190, 2002
32. Holland M, Yagi H, Takahashi N, Kato K, Savage CO, Goodall DM, Jefferis R: Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim Biophys Acta 1760: 669-677, 2006
33. Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, The TH, von dem Borne AE, Kallenberg CG: Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 37: 799-806, 1990
34. Tervaert JW, Mulder L, Stegeman CA, Elema J, Huitema M, The H, Kallenberg C: Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 52: 115-120, 1993
35. Brouwer E, Tervaert JW, Horst G, Huitema MG, van der Giessen M, Limburg PC, Kallenberg CG: Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 83: 379-386, 1991
36. Collin M, Olsen A: Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 69: 7187-7189, 2001
37. Hu N, Westra J, Huitema MG, Bijl M, Brouwer E, Stegeman CA, Heeringa P, Limburg PC, Kallenberg CG: Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: Anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils. Arthritis Rheum 60: 1548-1557, 2009
38. Franssen CF, Huitema MG, Muller Kobold AC, Oost-Kort WW, Limburg PC, Tiebosch A, Stegeman CA, Kallenberg CG, Tervaert JW: In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis. J Am Soc Nephrol 10: 1506-1515, 1999
39. Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F, Maeda N: Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 67: 1828-1836, 1999